Bimat + Applicators

Common use

The active ingredient in Bimat eye drops is Bimatoprost. Bimatoprost is a prostglandin analogue. Bimatoprost helps and promotes the growth, thickening and darkening of the eyelashes by stimulating the prostglandin in the eyelash follicles. After 12 to 16 weeks with daily use, you can see changes. You should not stop the treatment abruptly, as it will cause your eyelashes to return to their initial state

Dosage and direction

In order to apply the Bitmat eye drops to your eyelashes, you will also need to buy applicators which come in boxes of 30 pieces(for one month usage) will aid you to administer them. Please ensure that your hands are washed and you do not have any make up on. Remove your contact lenses as well. To apply the drug, squeeze one drop of it on the brush and then gently spread it over your eyelashes, on the upper eyelid. Do not use Bitmat eye drops on your lower eyelid. For maximum efficiency, do not wash your eyes fifteen minutes after the application and let your eyelashes dry. The brush can be used for a month and it is designed in such a way that it can reach the roots of your eyelashes. Do not expect to see immediate results, it is a long process. Do not apply the drug more than once per day, as it will not promote more hair growth.

Precautions

It is strongly recommended that you visit your doctor and consult with your pharmacist before starting to take Bitmat eye drops. Please tell your doctor if you are suffering from other conditions, pregnant, as well as telling him if you are allergic to any substances that may be contained by Bitmat eye drops. If Bitmat eye drops enter your eye, there is no need to panic or wash consistently, because they do no harm. Ensure that after every usage, you close the cap of the bottle.  Do not touch the tip of the lid because this may cause contamination which can lead to an infection of your eyes.

Contraindications

Some people may be allergic to the main active ingredient in Bimat eye drops. If this is your case do not use this drug. Symptoms of an allegric reaction may include chest pain, difficulty breathing, soreness of the eyes, redness of the eyes.

Do not continue your daily activities after immediate usage of the drug. Wait for a brief fifteen minutes in order for the impaired vision that may install after usage to go away.

Possible side effect

The side effects of Bitmat eye drops may include: eye irritation, excessive watering, itching, burning, stinging, light sensitivity, discoloration of the iris.

Some rare side effects of Bitmat eye drops include: swollen eyelids, impaired vision, eye pain, red eyelids.

If you are experiencing any of these side effects on a daily basis, please inform your physician.

Drug interaction

Do not use Bimat eye drops if you are already using one or more of the following drugs: latanoprost ophtalmic, bimatoprost topical, or if you are using other drugs that contain the Latisse or Xalatan active ingredients. Also, if you are suffering from uveitis, renal or liver disease, macular edema, do not use this drug.

Missed dose

If you forget to use the Bitmat eye drops on the scheduled time, use one dose as soon as you remember in the same day. Do not take a double dose the following day to make up for the one that you missed.

Overdose

Symptoms of overdose may include sensitivity to light and pink eyes. If this is the case, seek immediate medical attention.

Storage

Store the bottle in place which does not have access to direct sunlight, at room temperature. Also, be careful when closing the bottle cap. Please store away from children.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

Clinical Verification

Last Clinically Updated: August 15, 2026

Written By

Dr. Elena Vance, PharmD

Clinical Specialist in Neuropharmacology

Fact Checked By

Marcus Thorne, MS

Biomedical Data & FDA Label Verification

Medically Reviewed By

Dr. Arthur Campbell, MD

Board-Certified Psychiatrist (ABPN)